Clinical Trial Update: BHV-7000 Responsive Neurostimulation System (RNS) Study [Phase 1]

View source ↗

Summary

The BHV-7000 Responsive Neurostimulation System study for epilepsy is in Phase 1 and currently active but not recruiting, sponsored by Yale University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizures

Snippet

Sponsor: Yale University | Conditions: Epilepsy, Seizures | Phase 1 | Status: ACTIVE_NOT_RECRUITING